SparX to Present SPX-303 Phase 1 Updates at AACR 2025
21 Apr 2025 //
PR NEWSWIRE
SparX Biopharmaceutical Announces FDA Greenlight for IND Application of SPX-303
30 Oct 2023 //
PR NEWSWIRE
21 Apr 2025 //
PR NEWSWIRE
30 Oct 2023 //
PR NEWSWIRE